Ignite Creation Date:
2024-10-25 @ 8:00 PM
Last Modification Date:
2024-10-26 @ 3:42 PM
Study NCT ID:
NCT06641778
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-09-27
Brief Title:
Fecal Microbiota Transplantation in Patients With Multiple Drug Resistant Klebsiella Pneumoniae Pneumonia
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Fecal Microbiota Transplantation in Patients With Multiple Drug Resistant Klebsiella Pneumoniae Pneumonia
Status:
RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Multidrug-resistant Klebsiella pneumoniae MDR-KP infections account for 10 of all nosocomial infections and even with effective antibiotics the mortality rate is as high as 50 Intestinal bacteria transplantation can not only treat intestinal diseases but also inhibit the colonization and proliferation of drug-resistant bacteria This study explored the therapeutic value of fecal microbiota transplantation in patients with MDR-KP pneumonia
Detailed Description:
Intervention study controlled clinical study patients with multidrug-resistant Klebsiella pneumoniae pneumonia were randomly assigned to the experimental group conventional antibiotic treatment fecal microbiota transplantation and the control group conventional antibiotic treatment The clinical symptoms inflammatory indexes immune indexes intestinal microecology respiratory microecology and antibiotic resistance gene changes were compared between the two groups
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None